Intravenous Solutions Market research report is analyzed by Type and Nutrients for each of the geographic regions-North America, Europe, Asia-Pacific and Rest of World. The global Intravenous solutions market size includes by Type- Partial Parenteral Nutrition (PPN) & Total Parenteral Nutrition (TPN); by Nutrients-Carbohydrates, Salt and Electrolytes, Minerals and Vitamins and Amino Acids. Estimations and predictions for the total global IV solutions market are given by geographic regions. Business profiles of 15 major companies are discussed in the report. The report covers more than 140 companies that are engaged in IV Solutions and related products. Major Contract Research Organizations serving Intra venous Solution market are also covered in the Corporate Directory section of this report. Information related to product developments, partnerships, collaborations, and mergers and acquisitions is also included in the report. A total of 110 exclusive graphically represented exhibits complement the text.
Global Intravenous Solutions market is projected to grow at 12.21% compounded annually from 2005 through 2020. Several companies that supply intravenous solutions have come up with innovations in their product lines. An industry leader in this field, Baxter International, rapidly expanded its product line of pre-mixed frozen intravenous solutions. Abbot Labs designed a system in which bottles of powdered drugs could be directly introduced into the bag of intravenous fluid as required. The lids of these bottles are screwed open inside the sterile bags and the drugs are subsequently introduced into the solution and mixed by shaking. Intravenous feeding is the short-term administration of supplementary nutrients through a solution that is introduced into the vein. Peripheral intravenous feeding refers to infusion of the fluid in a small vein on the surface of an arm, leg or the scalp. On the other hand, central venous feeding refers to infusion into a large vein which is embedded deep within a body. Only limited quantities of nutrients can be administered through peripheral intravenous feeding as there is the danger of incurring phlebitis and/or clots (thrombi) if concentrated solutions are used. However, in central venous feeding it is possible to infuse concentration nutrient solutions as the rapid blood flow in the central veins can promptly dilute the solution thereby minimizing the possibility of causing irritation to the vein. When IV solutions are produced locally in medically emerging countries, the resulting return on initial investments can be quite small. It is estimated that profitability would stand at only 50% of the total production capacity. The production costs that are incurred in developing IV solutions are 45% to 65% lower than the existing market price for primary product lines. These estimates are based on U.S. cost figures. When the U.S. system of calculation is used, both direct and indirect labor costs are the largest cost factors. However, in developing nations, the labor cost is relatively low and the cost of IV solutions is much higher. Therefore, the actual production cost can be estimated to be 60% to 90% lower than the market price of the product. There is a very high demand for IV solutions. Therefore, even if a situation arises in which production is more than the local demand, there are still excellent prospects of making national sales as well as sales through exports. The raw materials that are required to produce IV solutions are easy to procure as they are readily available in local markets.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/30791-intravenous-solutions-market-research-report
Report by Chapter
I. Scope and Methodology: This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used.
II. Report Synopsis: Synopsis of the report summarizes the global Intravenous Solutions market by Type and Nutrient. Global market is also analyzed by geographic regions including North America, Europe, Asia-Pacific and Rest of World. The chapter provides market values in US$ (2005-2020) for each geographic region including the US, Canada, UK, Germany, France, Switzerland, Russia, Japan, China, India, Australia, South Korea, Brazil, Israel and South Africa. A List of major companies is also provided.
III. Market Dynamics: Market Dynamics chapter provides information on global markets for Intravenous Solutions. The chapter includes global market analysis (in US$) by geographic region; analysis of each region by both Type and Nutrient; brief business profiles of major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc. The section includes key market trends and an industry outlook.
IV. Product/Technology Research: This chapter gives an insight into Intravenous Solutions market through definitions, segmentation and applications. The chapter also includes product trends and potential opportunities. Various research activities in the field of Intravenous Solutions find a mention in this chapter.
V. Corporate Directory: This chapter provides a global region-wise list of 140+ companies, CROs/CMOs and academic institutions that offer Intravenous Solutions products and/or services.
VI. Patents Information: This chapter provides a compilation of worldwide patents related to Intravenous Solutions products/technologies.
- 16+ Intravenous Solutions Company Insight Profiles
- 156+ Company Directory Listing
Company Insight Profiles List
- Ajinomoto Co., Inc. (Japan)
- B. Braun Melsungen AG (Germany)
- Baxter (India) Pvt. Ltd. (India)
- Baxter International (USA)
- Claris Lifesciences Ltd. (India)
- Fresenius Kabi AG (Germany)
- Grifols International S.A. (Spain)
- Hospira, Inc. (USA)
- Kyowa Hakko Bio Co., Ltd. (Japan)
- Liqvor CJSC (Armenia)
- Marck Biosciences Ltd. (India)
- Otsuka Pharmaceutical Co., Ltd. (Japan)
- Pfizer, Inc. (USA)
- Sichuan Kelun Pharmaceutical Co., Ltd. (China)
- Sino-Swed Pharmaceutical Corp., Ltd. (China)
- Terumo Corporation (Japan)
Why Buy This Report?
This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –
Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential for your Products
Use Market Research for exploring new areas
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry
Get Actionable Information
Analytics and data presented in each report pertain to several parameters such as –
Global and Regional Market Sizes, Market Shares, Market Trends
Product (Global and Regional) Market Sizes, Market Shares, Market Trends
Key Companies By Sales, Brands, Products
Other Strategic Business Affecting Data
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)